Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.
BACKGROUND
The Rotterdam criteria for polycystic ovary syndrome (PCOS) defines discrete subgroups whose phenotypes are not yet clear.


OBJECTIVE
The phenotypic characteristics of women in the PCOS subgroups defined by the Rotterdam criteria were compared.


METHODS
The study was observational.


METHODS
Subjects were studied in an outpatient setting in Boston and Reykjavik.


METHODS
Four subgroups of subjects with PCOS defined by 1) irregular menses (IM), hyperandrogenism (HA), and polycystic ovary morphology (PCOM, n = 298); 2) IM/HA (n = 7); 3) HA/PCOM (n = 77); and 4) IM/PCOM (n = 36) and a group of controls (n = 64), aged 18-45 yr, were examined.


METHODS
Subjects underwent a physical exam; fasting blood samples for androgens, gonadotropins, and metabolic parameters; and a transvaginal ultrasound.


METHODS
The phenotype was compared between groups.


RESULTS
Ninety-seven percent of women with IM/HA had PCOM. Therefore, the groups with and without PCOM were combined. The Ferriman-Gallwey score and androgen levels were highest in the hyperandrogenic groups (IM/HA and HA/PCOM), whereas ovarian volume was higher in all PCOS subgroups compared with controls, as expected based on the definitions of the PCOS subgroups. Body mass index and insulin levels were highest in the IM/HA subgroup.


CONCLUSIONS
Subjects with PCOS defined by IM/HA are the most severely affected women on the basis of androgen levels, ovarian volumes, and insulin levels. Their higher body mass index partially accounts for the increased insulin levels, suggesting that weight gain exacerbates the symptoms of PCOS.
Welt
C K
CK
Reproductive Endocrine Unit, BHX 511, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114, USA. cwelt@partners.org
Gudmundsson
J A
JA
Arason
G
G
Adams
J
J
Palsdottir
H
H
Gudlaugsdottir
G
G
Ingadottir
G
G
Crowley
W F
WF
D000293:Adolescent; D000328:Adult; D000728:Androgens / Q000097:blood; D015992:Body Mass Index; D001835:Body Weight / Q000502:physiology*; D005260:Female; D006062:Gonadotropins / Q000097:blood; D006728:Hormones / Q000097:blood; D006801:Humans; D024821:Metabolic Syndrome / Q000097:blood / Q000453:epidemiology; D008660:Metabolism / Q000502:physiology*; D008875:Middle Aged; D010641:Phenotype; D010808:Physical Examination; D011085:Polycystic Ovary Syndrome / Q000145:classification*
D000728:Androgens; D006062:Gonadotropins; D006728:Hormones